Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. Depress Anxiety. 2011 Feb; 28(2):137-44.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.